Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd
000766.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$14.47B
Close$
$-0.03
100.2% downside
Current Fair Value
100.2% downsideOvervalued by 100.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $14.47 Billion |
|---|---|
| Enterprise Value | $16.14 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.04 |
| Beta | 0.7 |
| Outstanding Shares | 966,494,707 |
Return
| Return on Equity | 1.06% |
|---|---|
| Return on Assets | 0.52% |
| Return on Invested Capital | 2.84% |
Valuation & Multiples
| P/E Ratio | 591.7 |
|---|---|
| PEG | -426.37 |
| Price to Sales | 14.23 |
| Price to Book Ratio | 7.12 |
| Enterprise Value to Revenue | 14.99 |
| Enterprise Value to EBIT | 143.22 |
| Enterprise Value to Net Income | 656 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.87 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd
1,480 employees
CEO: Yufu Zhang Tonghua Golden-Horse Pharmaceutical Industry Co., Ltd. is a Chinese pharmaceutical firm actively involved in the full spectrum of drug development, from research and development to manufacturing and sales. Its therapeutic focus primarily...